A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)
Clinical trial NCT03207347 · COMPLETED
Trial details
- NCT number
- NCT03207347
- Sponsor
- University of Florida
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-13
- Primary completion
- 2022-08-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.